Histopathological comparison of topical therapy modalities for acute radiation proctitis in an experimental rat model

被引:27
作者
Korkut, Cagatay
Asoglu, Oktar [1 ]
Aksoy, Murat
Kapran, Yersu
Bilge, Hatice
Kiremit-Korkut, Nese
Parlak, Mesut
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Gen Surg, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Med, Dept Pathol, Istanbul, Turkey
[3] Istanbul Univ, Inst Oncol, Istanbul, Turkey
[4] Istanbul Univ, Istanbul Fac Med, Expt Med Res Inst, Istanbul, Turkey
关键词
acute radiation proctitis; mesalazine; formalin; betamethasone; misoprostol;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the prevalent topical therapeutic modalities available for the treatment of acute radiation proctitis compared to formalin. METHODS: A total of 120 rats were used. Four groups (n = 30) were analyzed with one group for each of the following applied therapy modalities: control, mesalazine, formalin, betamethasone, and misoprostol. A single fraction of 17.5 Gy was delivered to each rat. The rats in control group rats were given saline, and the rats in the other three groups received appropriate enemas twice a day beginning on the first day after the irradiation until the day of euthanasia. On d 5, 10, and 15, ten rats from each group were euthanized and a pathologist who was unaware of treatment assignment examined the rectums using a scoring system. RESULTS: The histopathologic scores for surface epithelium, glands (crypts) and lamina propria stroma of the rectums reached their maximum level on d 10. The control and formalin groups had the highest and mesalazine had the lowest, respectively on d 10. On the 15th d, mesalazine, betamethasone, and misoprostol had the lowest scores of betamethasone. CONCLUSION: Mesalazine, betamethasone, and misoprostol are the best topical agents for radiation proctitis and formalin has an inflammatory effect and should not be used. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:4879 / 4883
页数:5
相关论文
共 31 条
[1]
Baughan C A, 1993, Clin Oncol (R Coll Radiol), V5, P19, DOI 10.1016/S0936-6555(05)80689-2
[2]
Cavcic J, 2000, CROAT MED J, V41, P314
[3]
MANAGEMENT OF RADIATION PROCTITIS [J].
CUNNINGHAM, IGE .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1980, 50 (02) :172-178
[4]
DAS KM, 1989, GASTROENTEROL CLIN N, V18, P1
[5]
Systematic review for non-surgical interventions for the management of late radiation proctitis [J].
Denton, AS ;
Andreyev, HJN ;
Forbes, A ;
Maher, EJ .
BRITISH JOURNAL OF CANCER, 2002, 87 (02) :134-143
[6]
RADIATION-INJURY IN SURGICAL PATHOLOGY .3. SALIVARY-GLANDS, PANCREAS AND SKIN [J].
FAJARDO, LF ;
BERTHRONG, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1981, 5 (03) :279-296
[7]
FISCHER L, 1990, ACTA CHIR SCAND, V156, P801
[8]
FREUND U, 1987, STRAHLENTHER ONKOL, V163, P678
[9]
GILINSKY NH, 1983, Q J MED, V52, P40
[10]
Pharmacotherapy for chronic hemorrhagic radiation proctitis [J].
Gul, YA ;
Prasannan, S ;
Jabar, FM ;
Shaker, ARH ;
Moissinac, K .
WORLD JOURNAL OF SURGERY, 2002, 26 (12) :1499-1502